Press release
Prominent Calcium Channel Blocker Market Trend for 2025: Innovative Advancements In The Calcium Channel Blocker Market
Calcium Channel Blocker Market
The escalating rate of occurrences of cardiovascular diseases is projected to spur the calcium channel blocker market's expansion. Cardiovascular disease is a term referring to conditions impacting the heart or blood vessels. Calcium channel blockers (CCBs) are employed to decrease the chances of heart failure and stroke. Therefore, a growth in the rate of cardiovascular diseases will lead to increased demand for calcium channel blockers. For example, in August 2022, a US-based non-profit medical organization, the American College of Cardiology, published a report indicating that all four cardiovascular risk factors will see an increase from 2025 to 2060 in the United States. The highest proportional upward swing can be noticed in diabetes at 39.3%, equivalent to 55 million people, followed by dyslipidemia (27.6% representing 126 million), hypertension (25.1% representing 162 million) and obesity (18.3% representing 126 million). The report also highlighted that the most significant anticipated surges in cardiovascular disease rates were in stroke (33.8% equal to 15 million), heart failure (33.4% reaching 13 million), ischemic heart disease (30.7% equal to 29 million), and heart attack (16.9% to 16 million). Hence, the escalating rate of occurrences of cardiovascular diseases is a key driving factor for the expansion of the calcium channel blocker market.
Get Your Calcium Channel Blocker Market Report Here:
https://www.thebusinessresearchcompany.com/report/calcium-channel-blocker-global-market-report
What is the future CAGR of the calcium channel blocker market, and how will it impact industry expansion?
In recent times, the market size for calcium channel blocker has experienced robust growth. This market is forecasted to expand from $15.56 billion in 2024 to $16.62 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The surge in growth during the historic period can be accredited to factors like a rise in cardiovascular diseases, older population, advancements in medical studies, lifestyle changes, and elevated consciousness.
Expectations are pointed towards substantial growth in the calcium channel blocker market in the upcoming years. The market is projected to expand to $22.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.4%. The growth anticipated in this period is due to the escalating global impact of cardiovascular diseases, the trend towards personalized medicine, better healthcare accessibility, broadened applications, official regulatory approvals, and market expansion. The forecast period is likely to see trends such as market growth, developments in technology, a changing regulatory environment, competitive analysis, evolving patient preferences, and increased awareness.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9428&type=smp
What are the most significant trends transforming the calcium channel blocker market today?
The calcium channel blocker market is witnessing a growing trend towards product innovation. The major firms in the market are concentrating on creating novel products to maintain their foothold. An illustration of this came in June 2022 when CMP Pharma, an American pharmaceutical manufacturer, introduced Norliqva. This product is the only oral liquid solution of the besylate salt of amlodipine, which is a long-lasting calcium channel blocker. Norliqva, uniquely, is an oral solution of amlodipine, designed to manage hypertension in anyone aged 6 or older. The product eliminates the concerns and inconsistencies associated with crushing or formulating amlodipine tablets, ensuring uniform dosage and bioequivalence. Norliqva is specifically designed for a group of patients in need of amlodipine, but struggle with swallowing or cannot swallow at all.
Which key market segments comprise the calcium channel blocker market and drive its revenue growth?
The calcium channel blocker market covered in this report is segmented -
1) By Drug Class: Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes
2) By Disease Indications: Hypertension, Chest Pain, Arrhythmias
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Dihydropyridine: Amlodipine, Nifedipine, Felodipine, Nicardipine, Isradipine
2) By Benzodiazepine: Diazepam
3) By Phenylalkylamine: Verapamil
4) By Other Drug Classes: Bepridil, Lercanidipine, Cilnidipine
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9428
What regions are at the forefront of calcium channel blocker market expansion?
North America was the largest region in the calcium channel blocker market in 2024. The regions covered in the calcium channel blocker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the leading players fueling growth in the calcium channel blocker market?
Major companies operating in the calcium channel blocker market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Cadila Healthcare Limited, Covis Pharma BV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A., Clearsynth Labs Ltd., Searle LLC, Bayer AG, AstraZeneca plc, Wyeth-Ayerst Lederle Inc., GlaxoSmithKline Plc., AbbVie Inc., Silvergate Pharmaceuticals Inc., Exela Pharma Sciences LLC, Arbor Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9428&type=smp
What Is Covered In The Calcium Channel Blocker Global Market Report?
• Market Size Forecast: Examine the calcium channel blocker market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the calcium channel blocker market for a structured understanding.
• Key Players Overview: Analyze major players in the calcium channel blocker market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the calcium channel blocker market.
• Segment Contributions: Evaluate how different segments drive overall growth in the calcium channel blocker market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the calcium channel blocker market.
• Industry Challenges: Identify potential risks and obstacles affecting the calcium channel blocker market.
• Competitive Landscape: Review strategic developments in the calcium channel blocker market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent Calcium Channel Blocker Market Trend for 2025: Innovative Advancements In The Calcium Channel Blocker Market here
News-ID: 3890923 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
